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Abstract
Background: Fibromyalgia syndrome (FMS) presents a challenge for patients and health care staff across
many medical specialities. The aetiology is multi-dimensional, involving somatic, psychological and social
factors. Patients' views were obtained to understand their experience of living with this long-term
condition, using qualitative interviews.
Methods: 12 patients were recruited and stratified by age, gender and ethnicity from one rheumatology
outpatient clinic, and a departmental held database of patients diagnosed with FMS.
Results: Patients' accounts of their experience of FMS resonated well with two central concepts: social
identity and illness intrusiveness. These suggested three themes for the analytical framework: life before
and after diagnosis (e.g. lack of information about FMS, invisibility of FMS); change in health identity (e.g.
mental distress, impact on social life) and perceived quality of care (e.g. lack of contact with nurses,
attitudes of specialists). The information provided from one male participant did not differ from the female
patients, but black and ethnic community patients expressed a degree of suspicion towards the medication
prescribed, and the attitudes displayed by some doctors, a finding that has not been previously reported
amongst this patient group. Patients expected more consultation time and effective treatment than they
received. Subjective experiences and objective physical and emotional changes were non-overlapping.
Patients' accounts revealed that their physical, mental and social health was compromised, at times
overwhelming and affected their identity.
Conclusion: FMS is a condition that intrudes upon many aspects of patients' lives and is little understood.
At the same time, it is a syndrome that evokes uneasiness in health care staff (as current diagnostic criteria
are not well supported by objective markers of physiological or biochemical nature, and indeed because
of doubt about the existence of the condition) and places great demands on resources in clinical practice.
Greater attention needs to be paid to the links between the explanatory models of patients and staff, and
most important, to the interrelationship between the complex physical, psychological and social needs of
patients with FMS. Taking a less medical but more holistic approach when drawing up new diagnostic
criteria for FMS might match better individuals' somatic and psycho-social symptom profile and may result
in more effective treatment.
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Background
Fibromyalgia Syndrome (FMS) has been described as
'puzzling' [1], and is one of the most prevalent wide-
spread chronic pain conditions, affecting 0.1% to 3.0% of
the general population, and 2% to 16% of patients in all
clinical situations [2]. It has been recognised within med-
icine for over a century, and was identified as a distinct
clinical syndrome in the 1970s. However, its status as a
medical condition remains contested [3]. FMS has been
defined as 'a functional somatic syndrome that cannot be
explained as a conventionally defined medical disease'
[4]. Recent well-designed neuro-imaging studies have
revealed abnormal pain perception [5,6].
Little is understood about its precise pathogenesis,
although alterations in peripheral and central neuronal
hyper-excitability at spinal or brainstem level [7], altered
pain perception [8], and somatisation [9] have all been
suggested. The aetiology seems to be complex, involving
somatic, psychological and social factors, which form the
structure of this paper.
Psychological and social aspects commonly are rated as
important by patients and are often neglected [10] or
viewed differently by clinicians [11]. One third of patients
with FMS complain of emotional problems such as
depression or anxiety, which exacerbates their pain sensa-
tion [12]. The cause and effect relationship between pain
and emotional problems remains unresolved. These
symptoms are 'common, frequently persistent and are
associated with significant distress, disability and unnec-
essary expenditure of medical resources' [4].
FMS is rarely reported in children, and most patients are
in their 40s and 50s with a strong female preponderance
(90%) [8]. The syndrome often has a negative impact on
patients' daily life and on their ability to continue with
work. Currently offered treatment, such as Amitriptyline,
Cyclobenzaprine, physiotherapy, psychological treatment
and others is only marginally effective [4].
FMS falls under the category of medically unexplained
symptoms, in other words patients complain about phys-
ical symptoms that are disproportionate to a particular
physical disease [13,14]. Almost any medical speciality
seems to have one of these functional syndromes and they
are a challenge to clinicians [4,14]. In the UK somatic
complaints account for 35% of medical outpatients [15]
and 20% in primary care [15,16].
Clinical aspects of FMS
FMS is characterised by allodynia (pain induced by an
innocuous stimuli) and hyperalgesia (an increase
response to a painful stimuli). Patients experience diffuse
chronic pain that they frequently describe as occurring all
over the body. Diagnosis is usually made according to the
1990 American College of Rheumatology criteria [17],
which state pain must be present for at least 3 months in
all four quadrants of the body, and there must be over 11
out of 18 positive tenderpoints at pre-defined locations
on the body, identified by pain obtained by light pressure
(4 kg/cm2). Importantly, these criteria fail to account for
the wide range of symptoms that are commonly associ-
ated with FMS. The medical term 'syndrome' of FMS
reflects the multitude of vegetative and functional symp-
toms that patients with FMS frequently present, including
sleep disturbance, depression, anxiety, fatigue, morning
stiffness, irritable bowel syndrome, headache and
migraine. In addition, patients often experience a circui-
tous route through the health care system [18]. Patients
with FMS have symptoms that differ from those of indi-
viduals with other chronic pain syndromes, e.g. chronic
neck or back pain. They have often localised and increased
tenderness at predefined sites. Clinical signs of allodynia
are not necessary for the diagnosis of many chronic pain
conditions [17].
From a patient perspective, FMS is a problematic, invisible
condition that is often challenging to health care profes-
sionals. At issue is the psychological versus somatic
dichotomy, the moral credibility of patients, and the legit-
imacy of experience and treatment. All of these challenges
may jeopardize the therapeutic relationship [19,20]. Fur-
ther complicating matters, currently there is no effective
treatment for FMS that targets all symptoms, nor any con-
sensus on how to best manage the condition [21]. Treat-
ment recommendations are varied from palliating
symptoms [22], a multi-modal approach (e.g. exercises
combined with education and psychologically-based
interventions) [23] or to use across all functional syn-
dromes one diagnostic category with a multidisciplinary
approach, due to similarity in symptoms, epidemiology
and response to treatment [4]. Recent treatment guide-
lines from the US [24] and Europe [25] suggested that the
best approach is to treat patients based on their individual
somatic and psycho-social symptom profile. In the UK
Lord Darzi's recent report[26] emphasized the importance
of patients' experiences with the goal for NHS staff to
deliver an 'inclusive, high-quality, personal health serv-
ice'.
Social aspects of FMS
An informal hierarchy of medical specialities exists within
medicine [27]. Diseases that are chronic situated diffusely
in the lower parts of the body that cannot be investigated
or treated by technologically sophisticated procedures,
such as FMS and anxiety, are among the lowest ranked
conditions [28]. At a structural level, this hierarchy often
saddles patients with a heavily stigmatised health identity.
From the start of a patient's career, such a diagnosis mayBMC Musculoskeletal Disorders 2009, 10:124 http://www.biomedcentral.com/1471-2474/10/124
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compromise their identity and core integrity, especially as
the legitimacy of the diagnosis is frequently questioned by
medical staff [29]. In addition how individuals make
sense of, respond to, cope with, and self-manage their ill-
ness is deeply socially embedded, and varies not only
according to their health identity, but also to social status,
such as socio-economic position, age, gender, ethnicity,
religion, and disability [30].
Moreover, the notion of illness intrusiveness is defined as
illness-induced disruptions to patients' valued activities,
lifestyle and interests that compromise their quality of life
when living with a long-term illness, within the physical,
social and emotional domains [31,32]. Illness intrusive-
ness both mediates between the circumstances of the ill-
ness (e.g. pain, disability, fatigue) and its treatment (e.g.
side effects, complications) and impacts on person's state
of health (e.g. discomfort, contentment).
Within this wider clinical, social and NHS policy context,
this study reports the subjective experiences of patients,
from diverse ethnic backgrounds, who live with FMS with
specific emphasis on how this long-term condition influ-
ences their everyday lives, and their contact with primary
and secondary care.
This study is part of a collaborative project supported by
experts of the European League Against Rheumatism Task-
force. Its aim is to review the current diagnostic criteria of
FMS, and thereby to improve the standard of healthcare
currently provided. Firstly, the project will start with the
concept of FMS as a syndrome of chronic unexplained dif-
fuse pain as a broader baseline description than that used
by the 1990 American College of Rheumatology criteria
[17]. Secondly, it will identify characteristics of patients,
based on their personal views that may be used to classify
them into different subgroups in relation to differences in
aetiology, pathogenesis and response to possible treat-
ments. Thirdly, three systematic reviews will be conducted
of diagnostic criteria, symptoms and instruments used for
the evaluation of any of the criteria of FMS or unspecific
pain and associated symptoms. Finally evidence will be
synthesised through a Delphi method.
Method
Recruitment of patients
A purposive sample of 21 patients with FMS was
approached whilst at their visit to a rheumatology outpa-
tient clinic run by medical and nursing staff. Patients were
not frequent attendees in the rheumatology clinic studied.
Therefore additional patients who had previously
expressed an interest in participating in FMS research were
randomly selected from a departmentally held patient
database. They were selected by age, gender and ethnicity.
Patients were invited to participate in accordance with the
following inclusion criteria: FMS diagnosed by an experi-
enced clinician more than one year ago, over the age of 18
years, able to communicate effectively in English, and
with no significant learning, hearing or communication
difficulties. The exclusion criteria were: patients that were
seriously unwell.
Interview conduct
Almost all (11/12) interviews took place at the Medical
School as patients expressed preference to combine the
clinic appointment with their study participation. One
patient who was unable to travel was interviewed at home
at her request. All interviews were recorded and lasted
between one and two hours. Recruitment of new partici-
pants discontinued when no new key themes emerged
[33]. The researcher used a semi-structured interview
schedule based on recent literature [3] and a previous
study involving patients with rheumatoid arthritis [10].
Having been piloted for relevance and comprehensive-
ness of the topics covered, the final interview guide con-
sisted of four main areas: (i) experience of onset of illness;
(ii) development of FMS following diagnosis; (iii) the
impact on patients' lives, work and family; and (iv) their
expectations and experiences when seeking medical help
in primary and secondary care. The interviewer's nursing
background and extensive clinical knowledge gave her
insight into participants' illness experiences. This helped
to develop close rapport with patients and in return they
provided rich and detailed information. Local Ethics
Committee and Research and Development approvals
were obtained.
Data analysis
The interviews were all transcribed verbatim, coded and
analysed (content and discourse analyses) with the help
of qualitative computer software (NVivo) [34], including
simple counting [35]. The data was examined primarily
through content analysis (what participants' stated). Dis-
course analysis (how patients described their experiences)
was also employed [36,37], for example how interviewees
described how their self-confidence in private and public
gradually waned over time. In this way language was not
only viewed as a means of transmitting information or
stories, but also as a medium from which additional
knowledge could be obtained. This combined application
of content and discourse analysis has been endorsed by
other researchers [38].
Themes were identified by independently and repeatedly
reading the interview text and then formulating an initial
coding scheme by one author (HKL). Related codes were
used to generate representative themes that emerged from
the transcriptions. Dozens of initial codes and related
themes were discussed and then cross-checked with the
external qualitative researcher (SLH). For this paper, weBMC Musculoskeletal Disorders 2009, 10:124 http://www.biomedcentral.com/1471-2474/10/124
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describe each 'theme' (e.g. the lack of information
patients received about FMS following their diagnosis),
state how many interviewees discussed the theme (e.g. 11/
12) and provide an illustrative account. The single count-
ing procedure [35] is intended to give an indication of the
prevalence of the themes in the data, and should not be
understood as a basis for statistical generalisation to the
population.
Following discussion we further refined the codes by con-
stant comparison within and between the codes to ensure
they reflected the data. We then drew up a map to help us
to make links between the different themes, which we
then grouped into the overall themes. We reached a con-
sensus that three topics constituted our analytical frame-
work under which the data will be presented: (i) life
before and after diagnosis; (ii) change in health identity
[39,40]; and (iii) perceived quality of care. Moreover,
through further discussion we agreed that the significance
of the findings under these three headings became further
strengthened by linking them to two sociological concepts
of social identity and illness intrusiveness. They provided
context and served to confirm the relevance and reso-
nance for the key findings of our study.
The bold text within the accounts was included to reflect
when interviewees in their talk emphasised points by rais-
ing their voice or slowing down their speech.
Results
From the 21 patient approached, twelve agreed to take
part in the study, (11 female, 1 male). Seven were con-
tacted during their rheumatology outpatient clinic visits
and five through a departmentally held database of
patients with FMS. Of the nine participants who declined,
two were male and seven female; all had similar socio-
demographic backgrounds to the interviewees, although
the mean age was slightly younger (41 years vs. 49 years
for participants, see Table 1).
Life before and after diagnosis
All patients (12/12) described at least three factors that
they believed had contributed to the development of FMS.
Four categories emerged out of the diverse accounts: (i)
physical ailments with long-term pain (12/12), e.g. 'grow-
ing pain', accidents, surgical interventions, (ii) family his-
tory (9/12), e.g. diagnosis of arthritis or generalised aches
and pains by other family members; (iii) specific person-
ality type (6/12), e.g. working all the time, involvement in
competitive sport; (iv) mental stress (7/12), e.g. job loss,
bereavement, unhappy marriages.
'I used to go to work as a young woman; I worked up
in town and there was always an element of pain, but
not as I am now. ... I am in this marriage that isn't
happy, it is a dreadful marriage, after 48 years nearly I
think it's beginning to take its toll'. (Patient 12)
The majority of participants (11/12) had their diagnosis
confirmed by a rheumatologist or orthopaedist. Diagnosis
was made by medical staff after enquiring about symp-
toms, and by applying pressure to specific body tender-
points that can produce severe pain (7/12). Most patients
(8/12) had been referred by their GPs, or received the
diagnosis during their routine rheumatology outpatient
visits.
'It was in XX hospital and he [rheumatologist] did an
examination of pressing on certain parts of my anat-
omy - shoulders, back, body, wherever and it was quite
painful. It wasn't just pressure it was pain. And after
the diagnosis he [rheumatologist] said to me I was suf-
fering with this fibromyalgia'. (Patient 12)
Almost all patients (11/12) critically remarked that very
little or no information was given to them following their
FMS diagnosis. This required the interviewees to be proac-
tive in seeking information from other sources, such as
the internet, leaflets, self-help groups or books. This lack
of medical understanding about FMS made explanations
about the condition to patients, family, friends and col-
Table 1: Socio-demographic characteristics of 12 participants
Gender female 11, male 1
Disease duration Range: 5 months - 11 years
Mean 3 years
Mean age of patients range: 20-69 years
Mean: 49 years
Ethnicity (self-described) Black 1; Black African 1; Black British1; British/English/White 6; Lebanese 1; New Zealand/British 1; Peruvian 1
Family status married 5, married living apart 1; divorced 1; single 4; not specified 1
Place of birth (country) UK 8, outside Europe 4
Family dependents 4/12 patients (young children 3-18 years)
2/12 patients (caring for their older mothers)
Employment situation full-time work 3; temporary employment 1; retired on medical grounds 1; retired 2; unemployed 5.
Registered disabled 7/12 patientsBMC Musculoskeletal Disorders 2009, 10:124 http://www.biomedcentral.com/1471-2474/10/124
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leagues difficult. A few (3/12) stated they did not under-
stand the diagnosis at all.
'For me it [FMS] just feels like an all over body... like a
disease, I don't know, I can't really describe it. All I
know is that it just, well it takes its toll, it doesn't just
affect one part, and it affects your whole body'.
(Patient 4)
The invisibility of FMS was an additional difficulty facing
most patients (9/12). They reported an incongruity
between how they look to others 'from the outside' that
usually was not mirrored by how they felt 'inside'.
'Oh I'll put on my lipstick and get ready for work, dress
smart and they'll [colleagues] say: "oh you look lovely,
you look nice", but inside I feel really, really awful'.
(Patient 10)
All described some mixture of emotions, such as relief (5/
12), ambivalence (3/12), or negative reactions (4/12) fol-
lowing the formal confirmation of their FMS diagnosis.
'....FMS just feels sometimes engaging with life from
behind it, a big screen of glass where you can see
things going around you and you think: I want to be
part of that, I am going to want to be part of that. And
to do that, you have to kind of smash  the glass
through, but obviously you'll get hurt, there is going to
be a bit of pain or consequences if you do sort of
smash through'. (Patient 6)
The reactions of family members, friends and colleagues
were not straightforward, and seemed to reveal and
amplify the quality of pre-existing relationships that had
developed over time. The following contrasting accounts
(6/12 positive, 6/12 unsympathetic) illustrate two com-
mon responses:
'My family are so supportive, a small knit family but
very supportive, everybody helps'. (Patient 11)
'My family could not understand it. It was something
alien to them. My father was totally oblivious to it... he
just could not cope with it [diagnosis] at all'. (Patient
1)
Change in health identity
Patients' health identity appeared to gradually transform
following the diagnosis and the impact and intrusiveness
of the illness into their lives became increasingly appar-
ent. FMS affected patients physically, socially and men-
tally and seemed to progressively undermine their self-
confidence and sense of self.
Almost all (11/12) commented about their inability to
rely on their body in ways that had not been obvious
before the diagnosis. The most frequently used phrases
were 'very frustrating' and 'scary' or 'frightening'. In addi-
tion, their self-confidence gradually became undermined
in public, at work and in social situations, which in part
was attributed to the unpredictability of the illness course.
'It is frustrating, very frustrating, because you are really
not sure how you are going to be sometimes from one
day to the next, so that is difficult'... (Patient 3)
'I felt in a space of a year being amazingly competent
and confident and feeling on top of things to actually
the complete opposite, and not understanding why
and not understanding how it happened'. (Patient 6)
Physical problems
The descriptions of patients' pain experiences (12/12)
engendered the most detailed and lengthy data. Indeed,
'pain' was the most frequently used key word throughout
the interviews. In addition to reports of severe pain, hurt-
ing in the joints and muscles was amplified by a wide
range of additional sensations such as stiffness, spasms, or
burning.
'... it feels as though I am walking with a big cross
nailed on my back'. (Patient 12)
'Pain is everywhere... sometimes especially my left
arm, I feel like cutting it off... just taking it raw, no
anaesthetic nothing, it must be cut off'. (Patient 5)
What emerged from these detailed reports was a common
description of pain that: (i) spread from head to toe,
affecting most of their joints and muscles; (ii) took its toll
physically and mentally; (iii) triggered behaviour change;
and (iv) seemed constantly present. The pain appeared to
signify a disruption in that a third of patients (4/12) had
no recollection of any pain-free time in their lives since
diagnosis, and only a few (2/12) could vaguely remember
short periods of living pain free.
In addition to the overwhelming nature of pain, all partic-
ipants (12/12) complained about the lack of restful sleep
for many years that resulted in chronic fatigue for half of
them (6/12). One patient mentioned the tiredness as
more debilitating than the pain. The suggested causes of
insomnia were pain coupled with an uncomfortable stiff-
ness that was difficult to alleviate, particularly during the
night. For some (5/12) this lack of sleep had an impact on
their behaviour during the day or night, as the following
account illustrates:BMC Musculoskeletal Disorders 2009, 10:124 http://www.biomedcentral.com/1471-2474/10/124
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'Sleeplessness nights ... can you see the black circles
under my eyes, because I wake up at 2 o'clock in the
morning, then I wake up and feel right awake...and the
next day I feel tired, I just want to sleep on but I have
to get up and go to work ... I am extremely physically
tired ... I am so tired I just can't function as a normal
person'. (Patient 9)
Abdominal discomfort was another physical problem that
was commonly reported (11/12). The descriptions
referred to a range of specific or non-specific conditions,
e.g. irritable bowel syndrome, Crohn's disease, and
change in bowel habits, which were troublesome and
often embarrassing.
Apart from these debilitating symptoms of pain, fatigue
and abdominal discomfort, many (9/12) encountered dif-
ficulties with mobility, especially when travelling. Most
patients (7/12) had access to a car/taxi, but some relied on
public transport. Others made use of their Disability Liv-
ing Allowance and/or family members who provided
transportation.
'I use the bus. It is OK with the bus, but I only go to
those buses that are not full, so I can sit [down]. I can't
stand in the bus from one bus stop to the other, so I
wait until the rush hour is over and then I go out'.
(Patient 2)
Additional co-morbidities were common (11/12), for
example, non-specific symptoms such as frozen shoulder,
headaches, clumsiness and menopausal complaints.
Patients reported up to 10 co-morbid complaints, cover-
ing almost all body systems.
Mental Distress
Mental and neurological related distress in FMS appeared
to affect patients in three ways: in terms of depression/
anxiety; cognitive problems; or a lack of co-ordination.
The following phrases were articulated by many (11/12)
and reflected their degree of distress:
'I was a complete mess'; 'I was feeling suicidal'; 'very,
very weepy'; 'mentally and physically shattered'; 'feel-
ing very, very down'; 'I am in a mental cocoon, in a
cage, in a bubble'; 'I was at a low point, in a black
hole'.
The manifestation of 'feeling low' triggered changes in
behaviour, but at the same time, patients described
attempts to avoid 'spiralling down' in their mood.
'I get quite depressed, particular as I am getting older,
feeling less and less [physically] able. The major thing
about it is the moaning aspect actually, I hate it and I
keep thinking: moan, moan, and moan. I take regular
anti-depressants at night; listen to music, sometimes I
pray: "please Lord just take this pain away, I'm just so
sick and tired of it" '. (Patient 8)
Distressing symptoms such as an inability to remember
facts (5/12) also were brought up. Problems with memory
were referred to by some (3/12/) as 'fibro-fog' or 'foggy-
brained'. The following is an example of patients' prob-
lems with coordination.
'I sat up sometimes and smacked my head into the
door. So I now make sure the door [in my flat] is open,
because I can't coordinate properly, I just smack into
things and half of the time I am not realising it'.
(Patient 3)
Impact of FMS on patients' social life
Patients' social lives also became compromised, including
their determination to remain independent. Many (11/
12) reported changes in their social life after diagnosis,
which was mostly characterised as being less able to go
out and enjoy themselves with friends and family. A few
patients (2/12) had physical problems that caused embar-
rassment or isolation, and one chose work ahead of hav-
ing a social life.
'My social life is very limiting, very limiting... I always
need to sit down and it's very difficult going round
talking to people and I love people. I am a gregarious
person and that is very difficult and so I am tending to
lose out a bit'. (Patient 8)
At the time of the interview about half of the patients (5/
12) were unemployed due to the physical discomfort and
restrictions caused by FMS symptoms and three were
retired (3/12). Some (4/12) felt they were able to continue
with paid work (see Table 1) despite occasional unsympa-
thetic reactions by colleagues, and over a third (5/12)
expressed a sense of isolation in the work place.
'And at work... they [colleagues] do not understand it
[FMS]... they sort of forget sometimes.... we are not
allowed to leave our seat; we are not allowed to get a
drink of water. So I have to ask: "can I have a break?"....
I need to be able to move, otherwise I seize up, and
that makes me worse for the evening, but my col-
leagues are not going to see that'. (Patient 3, full time
work)
Lack of awareness about FMS seemed to play a role in how
patients experienced stigmatisation or discrimination in
public. Many (10/12) described encounters when they
were viewed as an 'invalid' by friends/colleagues, or they
described overhearing remarks about their obesity.BMC Musculoskeletal Disorders 2009, 10:124 http://www.biomedcentral.com/1471-2474/10/124
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Patients often referred to their deliberate choice not to use
a stick at work or in public to avoid embarrassment or
being asked direct questions about their illness.
'I am not at work on Thursdays, so they [colleagues]
say: "why are you not here on Thursdays" and some-
times I don't explain. But sometimes I have to explain;
and some people you know have looked at me as if to
say: "well you are a disabled person now; you are not
a full person any more"... (Patient 9)
In fact, most (7/12) were registered as disabled (see Table
1) and talked about their reactions when enquiring about
their entitlement to Disability Allowance. Half (6/12)
welcomed their additional income and special parking
badge and remarked how these contributed to a better
quality of life, e.g. to greater independence, mobility, and
comfort, despite the initially complicated bureaucracy.
Some (4/12) wanted to delay their application and others
(2/12) found the step problematic.
'Oh I so loved my work, it was really exciting... so
then... yes it's difficult isn't it [to ask for disability
allowance] but on the other hand it is a relief to actu-
ally get some help... at least it is helping us [wife and
me] out and ...I am really pleased to get disability
allowance'. (Patient 8)
Patients' self-determination while living with FMS was an
important attribute in their self-management. What
emerged from their detailed descriptions was a fine bal-
ance between a desire to remain independent as long as
possible (11/12), and also wanting and needing support
(9/12). Patients found ways of managing their lives by
making compromises and by sharing activities with the
help of supportive family members and friends (9/12).
Only two (2/12) talked about input from a formal care
supplier, e.g. Social Services, or state provided household
adaptations.
'I can do everything myself, shopping, cooking, clean-
ing, very, very slowly. I just do small amounts and
stop, small amounts and stop'... my daughter comes,
she helps me, she is very, very good'. (Patient 1)
Half of the interviewees (6/12) were married and they all
revealed ways in which the illness took its toll on their
relationships.
'FMS affected my life a lot, it affected my marriage and
my marriage broke down [and] my heart. I had a won-
derful husband, he was in Nigeria and I was in Lon-
don...' (Patient 11)
Finally, half of the interviewees (6/12) expressed worries
about how they would manage their illness in the near or
long-term future.
'I am so scared; my oldest daughter is not going to
look after me, who will look after me when I get
worse'? (Patient 7)
For some informants (2/12), stress was amplified by addi-
tional caregiver responsibilities for dependent family
members, e.g. old parents.
Perceived quality of care
A surprising finding was the patients' lack of regular con-
tact with nurses in both primary and secondary care (11/
12). In primary care, the main concern was the perceived
lack of time by GPs in their consultations (9/12). The
majority (7/12) provided positive comments, e.g. that the
GP was sympathetic or supportive, but some (3/12) com-
plained about GPs' (i) unresponsiveness to their needs,
and (ii) perceived function that was limited to prescribing
medication.
'He [GP] is understanding. He does not have much
time that is why I asked to see a rheumatologist. He is
so fast, only 5 minutes: "and what do you have? More
prescription ok, here you are, bye, bye" '. (Patient 2)
In contrast, patients' comments (12/12) about hospital
specialist outpatient care focused upon their expectations
about: (i) the professional attitudes and behaviour of spe-
cialists; and (ii) organisational aspects.
'I'm not happy ... my appointments have been can-
celled several times... I sat about two hours in the wait-
ing room and had a 15 minutes appointment and had
my medication changed and that was it, that was all...
that is not good enough'. (Patient 4)
Another notable finding was reflected in the critical com-
ments made by patients (4/12) who identified themselves
as members of black and ethnic communities. They
voiced directly and indirectly uneasiness about certain
aspects of their care (e.g. being prescribed drugs) and a
general mistrust towards health care professionals.
'I am on Amytriptiline to help with my sleep and other
tablets... I only take them when it is right for my body.
I don't like to be taken as a guinea pig. I don't trust
staff to deal with me in that way. I am the only person
who knows what it feels like to be ill, and what is good
for my body, I don't like other people to tell me and to
control me'. (Patient 7, Black)BMC Musculoskeletal Disorders 2009, 10:124 http://www.biomedcentral.com/1471-2474/10/124
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Most patients (9/12) were very resourceful in controlling
their symptoms through practical and mental distrac-
tions, but some (3/12) recalled crisis situations of unbear-
able and uncontrollable pain. Almost all (10/12)
expressed ambivalence in relation to the prescribed med-
ication. They were worried about two particular issues:
becoming dependent on medication and that the tablets
'masked' their overwhelming symptoms without curing
the underlying problem. These worries seemed to be
linked to their own beliefs about treatment and many
(11/12) felt that the prescribed drugs were ineffective in
relieving their pain and discomfort. Most admitted that
they followed their own intuition, rather than medical
advice.
'With my back, the more you put pressure on the more
you feel the pain. Ibuprofen cools the pain down a lit-
tle bit, it helps you to move around... the Doctor said
I can take Paracetamol... it relieves me a bit from the
pain...the one with the codeine [Co-Codamol] I don't
take anyway...'(Patient 5)
Apart from medication, many patients (10/12) were
offered physiotherapy as part of the treatment package.
While a few (4/12) made positive comments, for many
(6/12) the word physiotherapy brought up negative mem-
ories.
'Don't talk to me about physiotherapy, I hate it! I have
tried it. It did nothing for me. I hate it! It caused more
pain believe it or not. I did not think it would, but it
did. I was in agony. And it was only gentle physiother-
apy, but I did not like it'. (Patient 11)
Finally, many (9/12) had tried or used alternative medi-
cine/therapy in addition to their prescribed medicine.
Patients admitted reluctantly little long-term improve-
ment, apart from applications of heat in different forms
(7/12) (e.g. swimming in warm water or the use of a hot
water bottle).
Discussion
These in-depth interviews confirmed the many conse-
quences associated with FMS including severe negative
physical, mental, and social impacts. These sometimes
became intrusive and overwhelming. FMS is a diagnosis
that is contested between health care staff and patients.
Participants appeared to be caught between their daily
subjective experiences and attempts at self-management,
and their frustration having to prove their illness to health
care staff who often cannot objectively detect any physical
changes. This has also been described by other authors
[41,42]. Patients depend upon a medical diagnosis to
continue in their 'sick role' and receive some acknowledg-
ment of being unwell by family, friends and work col-
leagues. This notion has been identified by Parsons [43].
However, some of its aspects, the lack of objective indica-
tors that traditionally contribute to formalising a medical
diagnosis and FMS's long-term prognosis is problematic
in this context. As a consequence, these unresolved ten-
sions tend to surface for patients during their encounters
with health professionals. In fact many long-term condi-
tions now contribute more towards the global burden of
disease in high income countries than do acute diseases
[44]. Within the long-term condition paradigm, the tradi-
tional passive patient role is increasingly redundant [45].
Before discussing the results in detail, there are some
strengths and limitations that deserve attention. Many
reviews and publications of qualitative studies focused
mainly on women [3,46-50], due to the disproportionate
prevalence of FMS among females [8,13]. While our study
may have benefited from the inclusion of more than one
male patient, there were no notable differences by gender
with regards to physical and psycho-social experiences.
This is consistent with the findings from a study of men
with FMS [51] that revealed also parallel findings that
pointed towards difficulties in relation to identity and
dealing with overwhelming pain. This qualitative study
represents the views of a small number of patients from
one outpatient clinic and therefore, the findings are not
necessarily generalisable. However, the findings are
timely and do represent direct insights from the perspec-
tive of patients with FMS, and their views and quality of
health care provided within the NHS, priorities laid down
in a recent report [26]. To our knowledge, only one other
paper has been published about the views of black and
minority ethnic group patients with FMS [52].
Many of the participants did not work with a mean age of
49 years and over half were registered as disabled. This
indicates that our patient group appeared to experience a
more 'severe' form of FMS and therefore studies that
include people who are cared for by primary care only
would be important for future research.
Another consideration is this study's reliance on in-depth
interviews as our only method for extrapolating data. This
project may have been strengthened with methodological
triangulation, by administering questionnaires with vali-
dated scales representing some of the aspects of physical
and psychosocial functioning [53]. Obtaining the data
through focus groups was considered, but we anticipated
that patients preferred one to one interviews due to the
very private and personal disclosures, that in return pro-
vided us with rich information.
Physical and mental impact of FMS
The two main social concepts of illness intrusiveness
[31,32] and social identity [39,40] were strengthened andBMC Musculoskeletal Disorders 2009, 10:124 http://www.biomedcentral.com/1471-2474/10/124
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relevant to our findings. Specific manifestations of FMS
did seem to have a detrimental effect upon patients' sense
of self. In particular, widespread pain, abdominal discom-
fort, insomnia, and mood swings all contributed to a
changed sense of identity for many patients. These ele-
ments were highly inter-related, for example behavioural
changes that were triggered by pain in turn resulted in lack
of self-confidence. The invisibility of FMS, despite its
intrusiveness, presented patients with additional social
difficulties [54] and was portrayed by many as a discrep-
ancy between their outside appearance and their inner fra-
gility [48]. The lack of acceptance by significant others of
FMS as a 'proper' illness was experienced as deeply prob-
lematic [46]. This was compounded by the lack of knowl-
edge about FMS by the patients and the public, and
contributed to experiences of stigmatisation and discrim-
ination, as reported in other visible [55] and invisible
long term conditions [56,57]. Interestingly, several
patients said having a visible marker of their condition,
such as a walking stick or a wheelchair, was helpful to gain
greater legitimacy and respect. Such obvious helpful signs
have also been mentioned by patients with rheumatoid
arthritis [58].
Pain and muscle soreness were dominant symptoms and
heavily contributed to troubling themes in their lives, as
highlighted by other publications [30,46-50,57]. The
depictions of chronic pain were powerfully expressed
through picturesque talk. This can be interpreted as over-
statements and/or tensions that may occur within medical
consultations when people perceive their lives as control-
led or misunderstood by others [59]. It serves to empha-
sise the difference between one group to another [60], in
this case between the patient with FMS and health care
professional. Patients clearly pointed towards the rela-
tionships between body and mind and how pain, insom-
nia, and specific life events were often related to their
mental health. Therefore, it was apparent that patients
often found it difficult or impossible to separate physical
and mental pain [3,61]. Further, lack of restful sleep,
abdominal discomfort, and mood disturbances were
common features of distress that were frequently reported
by patients, but are not included in the 1990 diagnostic
criteria [17,62]. Some could not remember a pain-free
time since their diagnosis. A recent randomised controlled
trial of a sleep quality modifier showed improved mood
and fatigue and reduced pain that are an important step in
the treatment of patients with FMS [63].
Social implications of FMS
The debilitating physical and emotional symptoms had
socially limiting effects on many patients' lives. For exam-
ple, going out was less enjoyable and less spontaneous,
and transport and mobility became problematic. For
some this led to social isolation, in particular when
employment was no longer an option and relationships
became strained [30,64]. Not all patients with a long-term
condition find their social life curtailed or experience
loneliness, however, unemployment and difficulties in
relationships are common [58].
A determination to remain independent, even while
accepting help from others exemplifies the challenge of
finding balance of dependence and independence that
faces many people with long-term conditions. This is
closely linked with notions of respect and dignity through
maintaining self-control and self-responsibility
[48,57,65]. The uncertainty about the long-term course of
FMS made these self-management elements particularly
difficult to foresee or plan for the future, which contrib-
uted to additional anxiety and stress. Thus, many chose to
take life on a 'one day at a time' basis.
Views on quality of care
Patients' critical view of primary and secondary care is not
surprising, given the relative lack of understanding of
FMS, and controversy about its legitimacy [4]. GPs tend to
see themselves as specialists in long-term conditions,
although there is absence of evidence of effective collabo-
ration between primary and secondary care, and compre-
hensive management for patients with such conditions
[66]. The contribution of specialist rheumatology nurses
with this patient group recently has been highlighted [67].
The lack of consultation time with doctors was criticised
by patients, and this could be complemented by nurse
consultations.
Patients' reluctance to take medication as prescribed,
mostly in long-term conditions, is well known [68]. In
this study, mistrust of prescribed medication particularly
was found among patients from black and ethnic commu-
nities, as shown elsewhere [69]. They expressed their
uneasiness towards prescribed medication especially if
they felt that medical staff could not clearly communicate
the effects and side effects of the treatment. It is increas-
ingly important for health care practitioners to develop an
understanding about potential sensitivity from black and
ethnic minority patients about their reluctance to follow
advice e.g. medication concordance, change in life style or
health behaviour due to past experiences in the health
care system with sometimes perceived unfair or unaccept-
able treatment offered.
Conclusion
From the point of view of patients, FMS has been por-
trayed in this study as an overwhelming condition that
intrudes upon many aspects of their lives and is little
understood by health care professionals, friends, family
and the public. At the same time in the medical literature,
FMS is described as a syndrome that evokes uneasiness inBMC Musculoskeletal Disorders 2009, 10:124 http://www.biomedcentral.com/1471-2474/10/124
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health care staff (as current diagnostic criteria are not well
supported by objective markers of physiological or bio-
chemical nature and indeed because of doubt about the
existence of the condition at all) and places great demands
on resources in clinical practice. Greater attention needs
to be paid to the links between the explanatory models of
patients and staff, and most important, to the interrela-
tionship between the complex physical, psychological
and social needs of patients with FMS. Taking a less med-
ical but more holistic approach when drawing up new
diagnostic criteria for FMS might match better individuals'
somatic and psycho-social symptom profile and may
result in more effective treatment.
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